SCHEMBL709629

SCHEMBL709629

CCCCc1cccc(CCCC)c1CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.46
ALOX5 P09917 1/20 0.44
PTGS2 P35354 1/20 0.44
TYR P14679 1/20 0.42
BID P55957 3/20 0.42
MCL1 Q07820 3/20 0.42
BCL2L1 Q07817 2/20 0.42
BAK1 Q16611 2/20 0.42
KAT8 Q9H7Z6 2/20 0.42
PPARA Q07869 2/20 0.42
PPARG P37231 1/20 0.42
EP300 Q09472 1/20 0.42
KAT2A Q92830 1/20 0.42
KAT2B Q92831 1/20 0.42
KAT5 Q92993 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
GABRA1 P14867 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17417168 0.96 LIPG (0.43) LIPGALOX5PTGS2TYRBID
SCHEMBL29061944 0.92 LIPG (0.56) LIPGALOX5PTGS2TYRBID
SCHEMBL28581364 0.88 CYSLTR2 (0.42) LIPGALOX5PTGS2TYRBID
SCHEMBL4981073 0.88 BID (0.49) LIPGALOX5PTGS2TYRBID
SCHEMBL27648160 0.88 LIPG (0.43) LIPGALOX5PTGS2TYRBID
SCHEMBL9746434 0.86 GABRA1 (0.41) LIPGALOX5PTGS2BIDMCL1
SCHEMBL8800268 0.85 LIPG (0.39) LIPGALOX5PTGS2TYRBID
SCHEMBL819273 0.84 LIPG (0.45) LIPGALOX5PTGS2TYRBID
SCHEMBL17417165 0.83 GABRA1 (0.39) LIPGALOX5PTGS2GABRA1GABRG2
Ammonia Solution, Strong SCHEMBL9810933 0.82 LIPG (0.44) LIPGALOX5PTGS2TYRBID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116622787-A Cod liver oil rich in glyceride type n-3PUFA as well as preparation method and application thereof 福建省水产研究所(福建水产病害防治中心) 2023-08-22 CN claimed
CN-111472183-B Acid dye ink composition and manufacturing method thereof 福盈科技化学股份有限公司 2022-10-28 CN claimed
CN-111472183-A Acid dye ink composition and manufacturing method thereof 福盈科技化学股份有限公司 2020-07-31 CN claimed
CN-111329778-A Whitening essence and preparation method thereof 齐振乾 2020-06-26 CN claimed
CN-103589228-B High-adhesion, high-brilliant-silver and environment-friendly printing ink and preparation method thereof SUZHOU ANJIE TECHNOLOGY CO LTD 2014-12-10 CN claimed
CN-103589229-A Brilliant black environment-friendly printing ink and preparation method thereof SUZHOU ANJIE TECHNOLOGY CO LTD 2014-02-19 CN claimed
CN-103589228-A High-adhesion, high-brilliant-silver and environment-friendly printing ink and preparation method thereof SUZHOU ANJIE TECHNOLOGY CO LTD 2014-02-19 CN claimed
CN-122055166-A Compositions and methods for improving the bioavailability of active ingredients 长弘生物科技股份有限公司 2026-05-15 CN disclosed
US-12478562-B2 Dental restoration material composition KURARAY NORITAKE DENTAL INC. (JP) 2025-11-25 US disclosed
US-12343329-B2 Method for suppressing production of asenapine-N-oxide HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2025-07-01 US disclosed
EP-3542775-B1 COMPOSITION WITH EXCELLENT STORAGE STABILITY USING HIGHLY BASIC FILLER SHOFU INC (JP) 2025-04-02 EP disclosed
US-20250082591-A1 LIDOCAINE-CONTAINING PATCH HISAMITSU PHARMACEUTICAL CO (JP) 2025-03-13 US disclosed
US-12186287-B2 Lidocaine-containing patch HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2025-01-07 US disclosed
EP-2123247-A1 CURABLE COMPOSITION FOR DENTAL PURPOSES Kuraray Medical Inc. (JP) 2009-11-25 EP disclosed
EP-2119425-A1 DENTAL COMPOSITION Kuraray Medical Inc. (JP) 2009-11-18 EP disclosed
EP-0925717-B1 PESTICIDE APPLICATOR EARTH CHEMICAL CO (JP) 2008-10-15 EP disclosed
US-7101630-B2 Diarylamino group-containing copolymer, organic electroluminescent device, and method of producing hole transport layer for organic electroluminescent device KAWAMURA INSTITUTE OF CHEMICAL RESEARCH (JP) 2006-09-05 US disclosed
US-20050008893-A1 Diarylamino group-containing copolymer, organic electroluminescent device, and method of producing hole transport layer for organic electroluminescent device KAWAMURA INSTITUTE OF CHEMICAL RESEARCH (JP) 2005-01-13 US disclosed
WO-2001014639-A1 USE OF DIELS-ALDER ADDUCTS FOR PRODUCING PAPER NOPCO PAPER TECHNOLOGY HOLDING AS (NO) 2001-03-01 WO disclosed
EP-0925717-A1 PESTICIDE APPLICATOR Earth Chemical Co., Ltd. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12343329-B2 Method for suppressing production of asenapine-N-oxide TPMT, CBS, TST LIPG 4445/4885ALOX5 207/4885PTGS2 649/4885
US-12478562-B2 Dental restoration material composition CAD, MAT2B, RER1 LIPG 4670/4885ALOX5 596/4885PTGS2 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.